Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Natural killer cell activity and survival after azacitidine treatment in high-risk MDS. Leuk Lymphoma 2019 Oct;60(10):2343-2344

Date

05/24/2019

Pubmed ID

31120354

DOI

10.1080/10428194.2019.1613543

Scopus ID

2-s2.0-85066879883

Author List

Abedin SM, Platanias LC

Author

Sameem Abedin MD Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Azacitidine
Hematologic Tests
Humans
Killer Cells, Natural
Leukemia, Myeloid, Acute
Myelodysplastic Syndromes